Tenderwize
Back to tender search

Open House Biologics Discount Contracts 2026-24 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml)

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2027 · 346 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)

50/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The procedure is not a public procurement under EU directives; legal remedies are through social courts, not procuremen...

Missing the monthly deadline (3rd of previous month) may delay pharmacy software listing by one month.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Supply of Aflibercept 40 mg/ml (ATC: S01LA05) under discount contracts
  • Contracts concluded on non-exclusive basis with all eligible pharmaceutical entrepreneurs
Show full summary

Open House procedure by Techniker Krankenkasse (TK) for discount contracts on Aflibercept (ATC: S01LA05, 40 mg/ml). Any eligible pharmaceutical entrepreneur can join. No selection, no exclusivity. Contract max 12 months starting 01.08.2026, extendable by 12 months. Value not disclosed.

Risks

The procedure is not a public procurement under EU directives; legal remedies are through social courts, not procuremen...

Missing the monthly deadline (3rd of previous month) may delay pharmacy software listing by one month.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG
  • Must have a valid marketing authorization for the product or be entitled to market it
  • Seat must be in Germany, another EU member state, or EEA state

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Biologics Discount Contracts 2026-24 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml)

Conclusion of discount contracts with all eligible pharmaceutical entrepreneurs for Aflibercept 40 mg/ml.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jul 2026 - Jul 2027

Category

Pharmaceutical products

Deadline

Deadline Jul 30, 2027

Procurement Details

Publication date
04 Jun 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
385850-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24